Renalytix plc (RENXF) Return on equity 2020–2023
Renalytix plc (RENXF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-654.6%FY2023 · since FY2020: -61.9% → -654.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -654.6% | -506.7 pp |
| FY2022 | -147.9% | -98.5 pp |
| FY2021 | -49.4% | +12.4 pp |
| FY2020 | -61.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RENXF financial trends
RENXF RevenueRENXF Net incomeRENXF Net marginRENXF Gross profitRENXF Gross marginRENXF Operating incomeRENXF Operating marginRENXF Operating cash flowRENXF Free cash flowRENXF Capital expendituresRENXF Stock buybacksRENXF Dividends paidRENXF Total assetsRENXF Total liabilitiesRENXF Shareholders’ equityRENXF overview →